Enanta Pharmaceuticals Inc Cash Flow-to-Debt Ratio
Enanta Pharmaceuticals Inc cash flow-to-debt ratio. Enanta Pharmaceuticals Inc (ENTA) has a Cash Flow-to-Debt Ratio of -0.05x as of June 2026, meaning its operating cash flow of $-9.97 Million could theoretically repay 0% of its total liabilities ($195.80 Million) in one year. Check Enanta Pharmaceuticals Inc earnings quality ratio to evaluate the quality of earnings relative to operating cash generation.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Cash Flow-to-Debt Ratio of Enanta Pharmaceuticals Inc (2011–2025)
Cash flow-to-debt ratio of Enanta Pharmaceuticals Inc from 2011 to 2025. Historical debt coverage capacity for Enanta Pharmaceuticals Inc across 15 annual periods. Check ENTA total capital reinvestment ratio to assess the company's total reinvestment commitment from operating cash flow.
Enanta Pharmaceuticals Inc Cash Flow-to-Debt Ratio by Year (2011–2025)
Enanta Pharmaceuticals Inc cash flow-to-debt ratio by year from 2011 to 2025. Year-by-year debt coverage analysis for Enanta Pharmaceuticals Inc. For the full cash flow conversion analysis, see Enanta Pharmaceuticals Inc cash flow conversion.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | -0.09x | $-19.27 Million | $216.01 Million | ▲ +71.9% |
| 2024 | -0.32x | $-78.76 Million | $247.84 Million | ▲ +24.4% |
| 2023 | -0.42x | $-103.15 Million | $245.54 Million | ▲ +70.6% |
| 2022 | -1.43x | $-84.78 Million | $59.26 Million | ▲ +15.3% |
| 2021 | -1.69x | $-70.00 Million | $41.43 Million | ▼ -939.2% |
| 2020 | 0.20x | $7.09 Million | $35.21 Million | ▼ -92.3% |
| 2019 | 2.61x | $71.42 Million | $27.34 Million | ▲ +83.7% |
| 2018 | 1.42x | $29.22 Million | $20.55 Million | ▼ -32.6% |
| 2017 | 2.11x | $52.65 Million | $24.96 Million | ▼ -33.2% |
| 2016 | 3.16x | $35.81 Million | $11.34 Million | ▼ -59.4% |
| 2015 | 7.78x | $76.67 Million | $9.86 Million | ▲ +160.6% |
| 2014 | 2.98x | $20.18 Million | $6.76 Million | ▲ +82.2% |
| 2013 | 1.64x | $10.65 Million | $6.50 Million | ▼ -40.4% |
| 2012 | 2.75x | $22.62 Million | $8.23 Million | ▲ +1708.2% |
| 2011 | 0.15x | $24.02 Million | $158.06 Million | — |